Chartwell Investment Partners, LLC Cytokinetics Inc Transaction History

Chartwell Investment Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$63.75 - $108.06 $1.43 Million - $2.42 Million	-22,440 Reduced 84.83%	4,013 $281,000
Q4 2023 Feb 15, 2024	BUY	$26.88 - $83.49 $79,296 - $246,295	2,950 Added 12.55%	26,453 $2.21 Million
Q2 2023 Jul 25, 2023	BUY	$32.62 - $40.75 $37,252 - $46,536	1,142 Added 5.11%	23,503 $766,000
Q1 2023 Apr 14, 2023	SELL	$33.36 - $45.71 $193,854 - $265,620	-5,811 Reduced 20.63%	22,361 $787,000
Q4 2022 Feb 15, 2023	BUY	$35.77 - $51.11 $57,160 - $81,673	1,598 Added 6.01%	28,172 $1.29 Million
Q3 2022 Oct 27, 2022	BUY	$38.54 - $54.52 $35,880 - $50,758	931 Added 3.63%	26,574 $1.29 Million
Q2 2022 Aug 01, 2022	BUY	$33.93 - $48.92 $870,066 - $1.25 Million	25,643 New	25,643 $1.01 Million
Q4 2020 Feb 09, 2021	SELL	$15.26 - $28.61 $465,292 - $872,347	-30,491 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$20.58 - $28.96 $627,504 - $883,019	30,491 New	30,491 $660,000

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.62B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Chartwell Investment Partners, LLC with notifications on news.